{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:26:34Z","timestamp":1787048794095,"version":"build-2736575974"},"reference-count":33,"publisher":"Hamad bin Khalifa University Press (HBKU Press)","issue":"3","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Aerosol antibiotics directly target the respiratory tract, bypassing the poor lung penetration of many intravenous antibiotics. However, they seem like they could be useful for treating ventilator-associated pneumonia (VAP); not enough research has been done on how well inhaled and intravenous treatments work. The existing literature does not give definitive information regarding which method yields superior therapeutic outcomes.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objective:<\/jats:bold>\n                    To evaluate the therapeutic effects of intravenous versus inhaled colistin in treating\n                    <jats:italic>Acinetobacter<\/jats:italic>\n                    VAP in severe traumatic brain injury patients.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methodology:<\/jats:bold>\n                    This prospective, multicenter, randomized, double-blind study compared inhaled versus intravenous colistin for\n                    <jats:italic>Acinetobacter<\/jats:italic>\n                    VAP using clinical and laboratory markers of infection and organ function. It was conducted from February 1, 2023, to March 1, 2024, at four Ukrainian medical institutions in Kyiv, Ternopil, and Khmelnytsky.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Both routes significantly reduced leukocyte counts (\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.001) and clinical pulmonary infection score (CPIS) (\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.001). Inhaled colistin improved PaO\n                    <jats:sub>2<\/jats:sub>\n                    \/FiO\n                    <jats:sub>2<\/jats:sub>\n                    ratios from 337 to 343 mmHg (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.010), while intravenous colistin did not show a significant change (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.334). Intravenous administration better preserved systemic organ function, with sequential organ failure assessment (SOFA) scores worsening from 12 to 13 (\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.001), compared to inhalation, which worsened from 12 to 14 (\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.001). Neither route significantly affected sepsis incidence (inhalation 33% vs. intravenous 22.5%,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.116) or 28-day mortality (inhalation 27% vs. intravenous 20.6%,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.362). Male gender was an independent predictor of mortality (OR 0.44, 95% CI 0.20-0.99,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.046).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Post-treatment physiological status was the primary determinant of outcomes in\n                    <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                    VAP patients with severe traumatic brain injury.\n                  <\/jats:p>","DOI":"10.5339\/qmj.2026.54","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:42:15Z","timestamp":1787046135000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative effectiveness of intravenous versus inhalational antibiotic administration for the management of Acinetobacter pneumonia: A randomized controlled trial"],"prefix":"10.5339","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0654-9726","authenticated-orcid":true,"given":"Kostiantyn","family":"Krenov","sequence":"first","affiliation":[{"name":"Department of Surgery with a Course in the Basics of Dentistry, Vinnytsia National Medical University named after M.I. Pirogov, Khmelnytsky, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2886-7741","authenticated-orcid":true,"given":"Oleksandr","family":"Oliynyk","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine and Intensive Care, University of Rzeszow, Rzeszow, Poland"},{"name":"Department of Anaesthesiology and Intensive Care, Bogomolets National Medical University, Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0697-4864","authenticated-orcid":true,"given":"Maryna","family":"Mamonova","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care, Bogomolets National Medical University, Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2659-5762","authenticated-orcid":true,"given":"Svitlana","family":"Yaroslavska","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care, Bogomolets National Medical University, Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4049-6701","authenticated-orcid":true,"given":"Andriy","family":"Dobrorodniy","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3277","reference":[{"key":"B1","article-title":"Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities","author":"World Health Organization","year":"2017","unstructured":"World Health Organization\n\n. \nGuidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities\n. \n2017\n. \n\nhttps:\/\/iris.who.int\/server\/api\/core\/bitstreams\/5c6f2512-2f33-4e47-9b91-9edd1d780f01\/content"},{"key":"B2","series-title":"Lancet Reg Health Am","first-page":"101004","article-title":"World Health Organization priority antimicrobial resistance in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus and Enterococcus faecium healthcare-associated bloodstream infections in Brazil (ASCENSION): a prospective, multicentre, observational study","volume":"43:","author":"Antochevis\n \nLC","year":"2025;","unstructured":"Antochevis\n \nLC\n\n, \n\nWilhelm\n \nCM\n\n, \n\nArns\n \nB\n\n, \n\nSganzerla\n \nD\n\n, \n\nSudbrack\n \nLO\n\n, \n\nNogueira\n \nTCRL\n\n\n\n. \nWorld Health Organization priority antimicrobial resistance in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus and Enterococcus faecium healthcare-associated bloodstream infections in Brazil (ASCENSION): a prospective, multicentre, observational study\n. \nLancet Reg Health Am\n. \n2025;\n43:\n101004\n. \n\nhttps:\/\/doi.org\/10.1016\/j.lana.2025.101004"},{"issue":"3:","key":"B3","series-title":"PLoS One","first-page":"e0247832","article-title":"Ventilator-associated pneumonia among ICU patients in WHO Southeast Asian region: A systematic review","volume":"16","author":"Kharel\n \nS","year":"2021;","unstructured":"Kharel\n \nS\n\n, \n\nBist\n \nA\n\n, \n\nMishra\n \nSK\n\n\n. \nVentilator-associated pneumonia among ICU patients in WHO Southeast Asian region: A systematic review\n. \nPLoS One\n. \n2021;\n16\n3:\ne0247832\n. \n\nhttps:\/\/doi.org\/10.1371\/journal.pone.0247832"},{"key":"B4","series-title":"Antimicrob Resist Infect Control","first-page":"9","article-title":"Multi-drug resistant Acinetobacter species: A seven-year experience from a tertiary care center in Lebanon","volume":"7:","author":"Kanafani\n \nZA","year":"2018;","unstructured":"Kanafani\n \nZA\n\n, \n\nZahreddine\n \nN\n\n, \n\nTayyar\n \nR\n\n, \n\nSfeir\n \nJ\n\n, \n\nAraj\n \nGF\n\n, \n\nMatar\n \nGM\n\n\n\n. \nMulti-drug resistant Acinetobacter species: A seven-year experience from a tertiary care center in Lebanon\n. \nAntimicrob Resist Infect Control\n. \n2018;\n7:\n9\n. \n\nhttps:\/\/doi.org\/10.1186\/s13756-017-0297-6"},{"issue":"12:","key":"B5","series-title":"Microbiol Spectr","first-page":"e01570","article-title":"Development of a new Acinetobacter baumannii pneumonia rabbit model for the preclinical evaluation of future anti-infective strategies","volume":"12","author":"Albac\n \nS","year":"2024;","unstructured":"Albac\n \nS\n\n, \n\nAnzala\n \nN\n\n, \n\nBonnot\n \nD\n\n, \n\nDjama\n \nC\n\n, \n\nMereghetti\n \nL\n\n, \n\nJacqueline\n \nC\n\n\n\n. \nDevelopment of a new Acinetobacter baumannii pneumonia rabbit model for the preclinical evaluation of future anti-infective strategies\n. \nMicrobiol Spectr\n. \n2024;\n12\n12:\ne01570\n24\n. \n\nhttps:\/\/doi.org\/10.1128\/spectrum.01570-24"},{"issue":"10325:","key":"B6","series-title":"Lancet","first-page":"629","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022;","unstructured":"Antimicrobial Resistance Collaborators\n\n. \nGlobal burden of bacterial antimicrobial resistance in 2019: A systematic analysis\n. \nLancet\n. \n2022;\n399\n10325:\n629\n55\n. \n\nhttps:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0"},{"issue":"5:","key":"B7","series-title":"Infect Dis Ther","first-page":"1527","article-title":"Antimicrobial resistance in ventilator-associated pneumonia: Predictive microbiology and evidence-based therapy","volume":"12","author":"Alnimr\n \nA","year":"2023;","unstructured":"Alnimr\n \nA\n\n\n. \nAntimicrobial resistance in ventilator-associated pneumonia: Predictive microbiology and evidence-based therapy\n. \nInfect Dis Ther\n. \n2023;\n12\n5:\n1527\n52\n. \n\nhttps:\/\/doi.org\/10.1007\/s40121-023-00820-2"},{"issue":"2:","key":"B8","series-title":"Respir Med Case Rep","first-page":"102150","article-title":"Extensively drug-resistant Acinetobacter baumannii lung abscess and empyema in a patient with fulminant Mycoplasma pneumoniae pneumonia","volume":"53","author":"Yang\n \nS","year":"2025;","unstructured":"Yang\n \nS\n\n, \n\nWei\n \nC\n\n\n. \nExtensively drug-resistant Acinetobacter baumannii lung abscess and empyema in a patient with fulminant Mycoplasma pneumoniae pneumonia\n. \nRespir Med Case Rep\n. \n2025;\n53\n2:\n102150\n. \n\nhttps:\/\/doi.org\/10.1016\/j.rmcr.2024.102150"},{"key":"B9","series-title":"Int J Infect Dis","first-page":"107267","article-title":"Effect of colistin combined with sulbactam: 9 g versus 12 g per day on mortality in the treatment of carbapenems resistant Acinetobacter baumannii pneumonia: A randomized controlled trial","volume":"149:","author":"Ungthammakhun\n \nC","year":"2024;","unstructured":"Ungthammakhun\n \nC\n\n, \n\nVasikasin\n \nV\n\n, \n\nSimsiriporn\n \nW\n\n, \n\nJuntanawiwat\n \nP\n\n, \n\nChangpradub\n \nD\n\n\n. \nEffect of colistin combined with sulbactam: 9 g versus 12 g per day on mortality in the treatment of carbapenems resistant Acinetobacter baumannii pneumonia: A randomized controlled trial\n. \nInt J Infect Dis\n. \n2024;\n149:\n107267\n. \n\nhttps:\/\/doi.org\/10.1016\/j.ijid.2024.107267"},{"key":"B10","series-title":"Microb Pathog","first-page":"107454","article-title":"Combatting Acinetobacter baumannii pneumonia by multidrug codelivery of curcumin nanosuspensions and sulfamethoxazole with polymyxin B for targeted pediatric pulmonary inflammation and disease management","volume":"203:","author":"Hao\n \nJ","year":"2025;","unstructured":"Hao\n \nJ\n\n, \n\nYang\n \nR\n\n, \n\nMa\n \nX\n\n\n. \nCombatting Acinetobacter baumannii pneumonia by multidrug codelivery of curcumin nanosuspensions and sulfamethoxazole with polymyxin B for targeted pediatric pulmonary inflammation and disease management\n. \nMicrob Pathog\n. \n2025;\n203:\n107454\n. \n\nhttps:\/\/doi.org\/10.1016\/j.micpath.2025.107454"},{"key":"B11","series-title":"Centers for Disease Control and Prevention","article-title":"Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated pneumonia [PNEU]) event","author":"National Healthcare Safety Network","year":"2025","unstructured":"National Healthcare Safety Network\n\n. \nPneumonia (Ventilator-associated [VAP] and non-ventilator-associated pneumonia [PNEU]) event\n. \nCenters for Disease Control and Prevention\n. \n2025\n. \n\nhttps:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/6pscvapcurrent.pdf"},{"issue":"1:","key":"B12","series-title":"Pharmacotherapy","first-page":"10","article-title":"International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)","volume":"39","author":"Tsuji\n \nBT","year":"2019;","unstructured":"Tsuji\n \nBT\n\n, \n\nPogue\n \nJM\n\n, \n\nZavascki\n \nAP\n\n, \n\nPaul\n \nM\n\n, \n\nDaikos\n \nGL\n\n, \n\nForrest\n \nA\n\n\n\n. \nInternational Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)\n. \nPharmacotherapy\n. \n2019;\n39\n1:\n10\n39\n. \n\nhttps:\/\/doi.org\/10.1002\/phar.2209"},{"issue":"1:","key":"B13","series-title":"J Intensive Care Med","first-page":"26","article-title":"The utility of the clinical pulmonary infection score","volume":"24","author":"Rosbolt\n \nMB","year":"2009;","unstructured":"Rosbolt\n \nMB\n\n, \n\nSterling\n \nES\n\n, \n\nFahy\n \nBG\n\n\n. \nThe utility of the clinical pulmonary infection score\n. \nJ Intensive Care Med\n. \n2009;\n24\n1:\n26\n34\n. \n\nhttps:\/\/doi.org\/10.1177\/0885066608327097"},{"key":"B14","author":"SOFA Score: What it is and How to Use it in Triage","year":"2020","unstructured":"SOFA Score: What it is and How to Use it in Triage\n\n. \n2020\n. \n\nhttps:\/\/files.asprtracie.hhs.gov\/documents\/aspr-tracie-sofa-score-fact-sheet.pdf"},{"issue":"21:","key":"B15","series-title":"Medicine","first-page":"e10862","article-title":"The evaluation of acute physiology and chronic health evaluation II score, poisoning severity score, sequential organ failure assessment score combine with lactate to assess the prognosis of the patients with acute organophosphate pesticide poisoning","volume":"87","author":"Yuan\n \nS","year":"2018;","unstructured":"Yuan\n \nS\n\n, \n\nGao\n \nY\n\n, \n\nJi\n \nW\n\n, \n\nSong\n \nJ\n\n, \n\nMei\n \nX\n\n\n. \nThe evaluation of acute physiology and chronic health evaluation II score, poisoning severity score, sequential organ failure assessment score combine with lactate to assess the prognosis of the patients with acute organophosphate pesticide poisoning\n. \nMedicine\n. \n2018;\n87\n21:\ne10862\n. \n\nhttps:\/\/doi.org\/10.1097\/md.0000000000010862"},{"issue":"3:","key":"B16","series-title":"Bone Marrow Transplant","first-page":"452","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda\n \nY","year":"2013;","unstructured":"Kanda\n \nY\n\n\n. \nInvestigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics\n. \nBone Marrow Transplant\n. \n2013;\n48\n3:\n452\n8\n. \n\nhttps:\/\/doi.org\/10.1038\/bmt.2012.244"},{"issue":"1:","key":"B17","series-title":"Neurosurgery","first-page":"6","article-title":"Guidelines for the management of severe traumatic brain injury, fourth edition","volume":"80","author":"Carney\n \nN","year":"2017;","unstructured":"Carney\n \nN\n\n, \n\nTotten\n \nAM\n\n, \n\nO\u2019Reilly\n \nC\n\n, \n\nUllman\n \nJS\n\n, \n\nHawryluk\n \nGWJ\n\n, \n\nBell\n \nMJ\n\n\n\n. \nGuidelines for the management of severe traumatic brain injury, fourth edition\n. \nNeurosurgery\n. \n2017;\n80\n1:\n6\n15\n. \n\nhttps:\/\/doi.org\/10.1227\/NEU.0000000000001432"},{"key":"B18","author":"The Glasgow Structured Approach to Assessment of the Glasgow Coma Scale","year":"2026","unstructured":"The Glasgow Structured Approach to Assessment of the Glasgow Coma Scale\n\n. \n2026\n. \n\nhttps:\/\/www.glasgowcomascale.org\/"},{"issue":"2:","key":"B19","series-title":"Clin Biochem Rev","first-page":"85","article-title":"Acute kidney injury: Definition, pathophysiology and clinical phenotypes","volume":"37","author":"Makris\n \nK","year":"2016;","unstructured":"Makris\n \nK\n\n, \n\nSpanou\n \nL\n\n\n. \nAcute kidney injury: Definition, pathophysiology and clinical phenotypes\n. \nClin Biochem Rev\n. \n2016;\n37\n2:\n85\n98\n. \n\nhttps:\/\/pubmed.ncbi.nlm.nih.gov\/28303073\/"},{"key":"B20","article-title":"Acinetobacter baumannii \u2013 Symptoms and treatment of infections Acinetobacter baumannii","author":"Jurewicz\n \nA","year":"2023","unstructured":"Jurewicz\n \nA\n\n\n. \nAcinetobacter baumannii \u2013 Symptoms and treatment of infections Acinetobacter baumannii\n. \n2023\n. \n\nhttps:\/\/www.medonet.pl\/choroby-od-a-do-z\/choroby-zakazne,acinetobacter-baumannii---objawy-i-leczenie-zakazen-acinetobacter-baumannii,artykul,55732122.html"},{"key":"B21","article-title":"European antibiotic awareness day (EAAD) 2022","author":"European Centre for Disease Prevention and Control","year":"2022","unstructured":"European Centre for Disease Prevention and Control\n\n. \nEuropean antibiotic awareness day (EAAD) 2022\n. \n2022\n. \n\nhttps:\/\/antibiotic.ecdc.europa.eu\/en\/european-antibiotic-awareness-day-eaad-2022"},{"issue":"8:","key":"B22","series-title":"JAMA","first-page":"762","article-title":"Assessment of clinical criteria for sepsis: For the third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Seymour\n \nCW","year":"2016;","unstructured":"Seymour\n \nCW\n\n, \n\nLiu\n \nVX\n\n, \n\nIwashyna\n \nTJ\n\n, \n\nShankar-Hari\n \nM\n\n, \n\nSinger\n \nM\n\n, \n\nDeutschman\n \nCS\n\n\n\n. \nAssessment of clinical criteria for sepsis: For the third international consensus definitions for sepsis and septic shock (Sepsis-3)\n. \nJAMA\n. \n2016;\n315\n8:\n762\n74\n. \n\nhttps:\/\/doi.org\/10.1001\/jama.2016.0288"},{"issue":"5:","key":"B23","series-title":"Clin Infect Dis","first-page":"e61","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil\n \nAC","year":"2016;","unstructured":"Kalil\n \nAC\n\n, \n\nMetersky\n \nML\n\n, \n\nKlompas\n \nM\n\n, \n\nMuscedere\n \nJ\n\n, \n\nSweeney\n \nDA\n\n, \n\nPalmer\n \nLB\n\n\n\n. \nManagement of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society\n. \nClin Infect Dis\n. \n2016;\n63\n5:\ne61\n111\n. \n\nhttps:\/\/doi.org\/10.1093\/cid\/ciw353"},{"key":"B24","series-title":"J Pharmacol Toxicol Methods","first-page":"58","article-title":"Penetration of antimicrobials to pulmonary epithelial lining fluid and muscle and impact of drug physicochemical properties determined by microdialysis","volume":"78:","author":"Rottboll\n \nLAH","year":"2016;","unstructured":"Rottboll\n \nLAH\n\n, \n\nFriis\n \nC\n\n\n. \nPenetration of antimicrobials to pulmonary epithelial lining fluid and muscle and impact of drug physicochemical properties determined by microdialysis\n. \nJ Pharmacol Toxicol Methods\n. \n2016;\n78:\n58\n65\n. \n\nhttps:\/\/doi.org\/10.1016\/j.vascn.2015.11.007"},{"issue":"1:","key":"B25","series-title":"Ann Intensive Care","first-page":"26","article-title":"Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: A prospective, randomized trial","volume":"6","author":"Abdellatif\n \nS","year":"2016;","unstructured":"Abdellatif\n \nS\n\n, \n\nTrifi\n \nA\n\n, \n\nDaly\n \nF\n\n, \n\nMahjoub\n \nK\n\n, \n\nNasri\n \nR\n\n, \n\nLakhal\n \nSB\n\n\n\n. \nEfficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: A prospective, randomized trial\n. \nAnn Intensive Care\n. \n2016;\n6\n1:\n26\n. \n\nhttps:\/\/doi.org\/10.1186\/s13613-016-0127-7"},{"issue":"2:","key":"B26","series-title":"Intensive Care Med","first-page":"192","article-title":"Aerosol therapy in intensive and intermediate care units: Prospective observation of 2808 critically ill patients","volume":"42","author":"Ehrmann\n \nS","year":"2016;","unstructured":"Ehrmann\n \nS\n\n, \n\nRoche-Campo\n \nF\n\n, \n\nBodet-Contentin\n \nL\n\n, \n\nRazazi\n \nK\n\n, \n\nHautefort\n \nA\n\n, \n\nVerroust\n \nN\n\n\n\n. \nAerosol therapy in intensive and intermediate care units: Prospective observation of 2808 critically ill patients\n. \nIntensive Care Med\n. \n2016;\n42\n2:\n192\n201\n. \n\nhttps:\/\/doi.org\/10.1007\/s00134-015-4122-5"},{"issue":"5:","key":"B27","series-title":"Clin Infect Dis","first-page":"670","article-title":"What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression","volume":"54","author":"Florescu\n \nDF","year":"2012;","unstructured":"Florescu\n \nDF\n\n, \n\nQiu\n \nF\n\n, \n\nMcCartan\n \nMA\n\n, \n\nMindru\n \nC\n\n, \n\nFey\n \nPD\n\n, \n\nKalil\n \nAC\n\n\n\n. \nWhat is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression\n. \nClin Infect Dis\n. \n2012;\n54\n5:\n670\n80\n. \n\nhttps:\/\/doi.org\/10.1093\/cid\/cir934"},{"issue":"12:","key":"B28","series-title":"Antimicrob Agents Chemother","first-page":"7331","article-title":"Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) after aerosol and intravenous administration in critically ill patients","volume":"58","author":"Boisson\n \nM","year":"2014;","unstructured":"Boisson\n \nM\n\n, \n\nJacobs\n \nM\n\n, \n\nGr\u00e9goire\n \nN\n\n, \n\nGobin\n \nP\n\n, \n\nMarchand\n \nS\n\n, \n\nCouet\n \nW\n\n\n\n. \nComparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) after aerosol and intravenous administration in critically ill patients\n. \nAntimicrob Agents Chemother\n. \n2014;\n58\n12:\n7331\n9\n. \n\nhttps:\/\/doi.org\/10.1128\/aac.03510-14"},{"key":"B29","series-title":"Ther Adv Respir Dis","first-page":"1753466619885529","article-title":"Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria","volume":"13:","author":"Choe\n \nJ","year":"2019;","unstructured":"Choe\n \nJ\n\n, \n\nSohn\n \nYM\n\n, \n\nJeong\n \nSH\n\n, \n\nPark\n \nHJ\n\n, \n\nKim\n \nSH\n\n, \n\nKim\n \nMJ\n\n\n\n. \nInhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria\n. \nTher Adv Respir Dis\n. \n2019;\n13:\n1753466619885529\n. \n\nhttps:\/\/doi.org\/10.1177\/1753466619885529"},{"issue":"10:","key":"B30","series-title":"Clin Infect Dis","first-page":"1238","article-title":"Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: A matched case-control study","volume":"51","author":"Kofteridis\n \nDP","year":"2010;","unstructured":"Kofteridis\n \nDP\n\n, \n\nAlexopoulou\n \nC\n\n, \n\nValachis\n \nA\n\n, \n\nMaraki\n \nS\n\n, \n\nDimopoulou\n \nD\n\n, \n\nGeorgopoulos\n \nD\n\n\n\n. \nAerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: A matched case-control study\n. \nClin Infect Dis\n. \n2010;\n51\n10:\n1238\n44\n. \n\nhttps:\/\/doi.org\/10.1086\/657242"},{"issue":"1:","key":"B31","series-title":"Ann Intensive Care","first-page":"73","article-title":"Aerosol delivery with two ventilation modes during mechanical ventilation: A randomized study","volume":"6","author":"Dugernier\n \nJ","year":"2016;","unstructured":"Dugernier\n \nJ\n\n, \n\nReychler\n \nG\n\n, \n\nWittebole\n \nX\n\n, \n\nRoeseler\n \nJ\n\n, \n\nDepoorter\n \nM\n\n, \n\nSottiaux\n \nT\n\n\n\n. \nAerosol delivery with two ventilation modes during mechanical ventilation: A randomized study\n. \nAnn Intensive Care\n. \n2016;\n6\n1:\n73\n. \n\nhttps:\/\/doi.org\/10.1186\/s13613-016-0169-x"},{"key":"B32","series-title":"J Crit Care","first-page":"154315","article-title":"Nebulized colistin as the adjunctive treatment for ventilator-associated pneumonia: A systematic review and meta-analysis","volume":"77:","author":"Zhang\n \nX","year":"2023;","unstructured":"Zhang\n \nX\n\n, \n\nCui\n \nX\n\n, \n\nJiang\n \nM\n\n, \n\nHuang\n \nS\n\n, \n\nYang\n \nM\n\n\n. \nNebulized colistin as the adjunctive treatment for ventilator-associated pneumonia: A systematic review and meta-analysis\n. \nJ Crit Care\n. \n2023;\n77:\n154315\n. \n\nhttps:\/\/doi.org\/10.1016\/j.jcrc.2023.154315"},{"issue":"3:","key":"B33","series-title":"Crit Care Med","first-page":"527","article-title":"The role of aerosolized colistin in the treatment of ventilator-associated pneumonia: A systematic review and meta-analysis","volume":"43","author":"Valachis\n \nA","year":"2015;","unstructured":"Valachis\n \nA\n\n, \n\nSamonis\n \nG\n\n, \n\nKofteridis\n \nDP\n\n\n. \nThe role of aerosolized colistin in the treatment of ventilator-associated pneumonia: A systematic review and meta-analysis\n. \nCrit Care Med\n. \n2015;\n43\n3:\n527\n33\n. \n\nhttps:\/\/doi.org\/10.1097\/ccm.0000000000000771"}],"container-title":["Qatar Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.qscience.com\/view\/journals\/qmj\/2026\/3\/article-54.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.qscience.com\/downloadpdf\/journals\/qmj\/2026\/3\/article-54.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.qscience.com\/downloadpdf\/journals\/qmj\/2026\/3\/article-54.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:42:16Z","timestamp":1787046136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.qscience.com\/view\/journals\/qmj\/2026\/3\/article-54.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":33,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.5339\/qmj.2026.54","relation":{},"ISSN":["2227-0426"],"issn-type":[{"value":"2227-0426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}